Prostate Cancer Treatment: Options for Every Stage
Prostate cancer develops when abnormal cells in the prostate gland grow uncontrollably. It is one of the most common cancers affecting men. The most suitable prostate cancer treatment depends on the cancer stage, its grade, PSA level, the patient's age and overall health.
Treatment options include active surveillance, surgery, radiation therapy, hormone therapy, chemotherapy and selected targeted treatments. Some patients need immediate treatment, while others can safely monitor their cancer under medical supervision.
At Modern Cancer Hospital Guangzhou Malaysia, patients can enquire about available treatment approaches and discuss their individual circumstances with the medical team.
This guide explains how prostate cancer is diagnosed, the available treatment options, potential side effects and important questions to ask before starting treatment.
If you are diagnosed as Prostate Cancer,please click online consultation to contact us.
What Is Prostate Cancer?
The prostate is a small gland located below the bladder and in front of the rectum. It produces fluid that forms part of semen.
Prostate cancer occurs when abnormal prostate cancer cells grow and multiply. Some cancers grow slowly and remain within the prostate gland for years. Others grow more quickly and may spread to nearby tissues, lymph nodes, bones or other parts of the body.
The most common type is prostate adenocarcinoma, which develops in the glandular cells of the prostate. Other, less common types include ductal adenocarcinoma and certain neuroendocrine or other rare tumours.
The type and behaviour of the cancer influence which treatment options may be appropriate.
Symptoms and Early Detection of Prostate Cancer
Early prostate cancer may not cause noticeable symptoms. When symptoms occur, they can include:
Frequent urination, particularly at night
Difficulty starting or stopping urination
A weak or interrupted urine stream
A feeling that the bladder has not emptied completely
Blood in the urine or semen
Persistent pain in the back, hips or bones in more advanced disease
These symptoms do not necessarily indicate cancer. Benign prostate enlargement and other conditions can cause similar problems.
Men should seek medical assessment if they develop persistent urinary symptoms, blood in their urine or other concerning changes.
How Is Prostate Cancer Diagnosed?
Doctors use several tests to assess possible prostate cancer and determine the extent of the disease.
Prostate-specific antigen (PSA) test: Measures PSA, a protein produced by the prostate. A raised PSA level may occur with prostate cancer, but it can also result from benign enlargement, inflammation or infection.
Digital rectal examination (DRE): Allows a doctor to assess the prostate for unusual firmness or irregularities.
Magnetic resonance imaging (MRI): Provides detailed images of the prostate and helps identify suspicious areas and guide biopsy decisions.
Prostate biopsy: A tissue sample is examined under a microscope to confirm whether cancer is present and assess its characteristics.
Cancer staging scans: Depending on the patient's risk and clinical findings, doctors may recommend CT, bone imaging or prostate-specific membrane antigen (PSMA) PET/CT to assess possible spread.
Not every patient needs every investigation. The medical team will select tests according to the individual case.
Understanding the Prostate Cancer Pathology Report
A pathology report helps doctors understand how aggressive the cancer may be and which treatment options should be considered.
1. Gleason Score and Grade Group
The Gleason score describes how prostate cancer cells look under a microscope. It helps estimate how the cancer may behave.
A higher score generally indicates more abnormal cancer cells and a greater risk of aggressive disease. Doctors may also use the Grade Group system to communicate the cancer's grade.
Read more about the prostate cancer pathology report and Gleason score.
2. PSA Level
PSA is an important marker used in prostate cancer assessment and follow-up. Doctors interpret it alongside biopsy findings, examination results and imaging.
A PSA result alone cannot confirm or exclude prostate cancer.
3. Cancer Staging
Staging describes the size and extent of the cancer and whether it has spread beyond the prostate.
Doctors consider the tumour, lymph node involvement and distant metastases when determining the stage. Staging helps guide the choice between local treatment and treatments that act throughout the body.
Learn more about prostate cancer staging.
Interpretation of Prostate Cancer Pathology Report
• Pathologic grade of prostate cancer- Gleason Score
• Prostate cancer and early indicator-PSA level
Prostate Cancer Stages and Treatment Options
Prostate cancer is commonly classified into Stages I to IV. The stage, cancer grade and risk category all influence treatment decisions.
Stage I: Early-Stage Prostate Cancer
The cancer is generally confined to the prostate and may be small or low grade.
For selected patients with low-risk disease, active surveillance may be appropriate. This involves regular monitoring rather than immediate treatment.
Other options include radical prostatectomy or radiation therapy when treatment is recommended.
Stage II: Localised Prostate Cancer
The cancer remains within the prostate but may have a higher grade, a larger tumour or other features that increase its risk.
Treatment may include active surveillance for carefully selected patients, radical prostatectomy or radiation therapy. Some patients may also need hormone therapy.
Stage III: Locally Advanced Prostate Cancer
The cancer may have grown beyond the prostate or into nearby structures. The exact extent of disease varies.
Treatment may involve radiation therapy combined with hormone therapy, surgery in selected cases or a combination of treatments.
The medical team will consider the likelihood of recurrence and whether additional treatment is needed.
Stage IV: Advanced or Metastatic Prostate Cancer
Stage IV disease may involve nearby lymph nodes or distant organs, particularly the bones.
Treatment depends on where the cancer has spread, whether it responds to hormone therapy, previous treatments and the patient's general health.
Options may include hormone therapy, androgen receptor pathway inhibitors, chemotherapy, radiation therapy, targeted treatment for selected molecular findings or radiopharmaceutical therapy in appropriate cases.
Treatment for advanced prostate cancer often aims to control the disease, relieve symptoms, maintain quality of life and extend survival.
These stage descriptions are general. The precise treatment plan should be based on specialist assessment and current clinical guidance.
Prostate Cancer Stages and 5-year Relative Survival Rate
Prostate Cancer Stage I: 90-95%;
Prostate Cancer Stage II: 60-70%;
Prostate Cancer Stage III: 30-40%;
Prostate Cancer Stage IV: 20%.
Prostate Cancer didn’t show any symptom in early stage, 80% of prostate cancer patients are diagnosed in advanced stage and have poor prognosis. Therefore, Early detection is one of crucial factors for prostate cancer treatment.
Prostate Cancer Treatment Options
There is no single standard treatment suitable for every patient. Doctors consider the cancer's risk category, stage, PSA level, biopsy findings, general health and personal preferences before recommending a treatment plan.
1. Active Surveillance
Active surveillance is an option for selected patients with low-risk prostate cancer and some carefully selected patients with favourable intermediate-risk disease.
Instead of treating the cancer immediately, doctors monitor it closely. Monitoring may include PSA tests, prostate examinations, MRI scans and repeat biopsies when appropriate.
Treatment can begin if the cancer shows signs of progression.
Potential benefits:
Avoids or delays treatment-related side effects
Helps preserve urinary and sexual function while treatment is deferred
Allows treatment to begin if monitoring identifies meaningful changes
Limitations and risks:
Active surveillance requires regular follow-up. There is a risk that the cancer may progress between assessments, so patients must follow the monitoring schedule agreed with their doctor.
Active surveillance is not the same as ignoring the cancer. It is a structured management plan designed for suitable patients.
2. Radical Prostatectomy
Radical prostatectomy is surgery to remove the entire prostate gland and usually the seminal vesicles. Nearby lymph nodes may also be removed when indicated.
It is a treatment option for selected patients whose cancer is localised or locally advanced and considered suitable for surgery.
The operation may be performed through an open approach or using minimally invasive techniques, including laparoscopic or robot-assisted surgery where available.
Potential benefits:
Removes the prostate containing the tumour
Provides tissue for detailed pathological examination
May offer long-term disease control or a cure in appropriately selected patients
Possible risks and side effects:
Patients may experience urinary incontinence, erectile dysfunction, bleeding, infection or other surgical complications. Recovery varies according to the procedure and individual health.
Some patients need additional treatment if the pathology results or follow-up tests indicate persistent or recurrent disease.
3. External Beam Radiation Therapy
External beam radiation therapy (EBRT) uses high-energy radiation directed at the prostate or other targeted areas.
It may be used to treat localised prostate cancer or, in combination with hormone therapy, certain higher-risk or locally advanced cancers.
Radiation therapy can also be used to relieve pain caused by cancer that has spread to the bones.
Treatment may involve multiple sessions over several days or weeks, depending on the technique and treatment plan.
Potential benefits:
Treats the tumour without removing the prostate
Can be used for patients who are not suitable for surgery
Can be combined with hormone therapy when appropriate
Possible side effects:
Patients may develop urinary frequency, discomfort during urination, bowel irritation, fatigue or changes in sexual function. Some effects improve after treatment, while others may persist or appear later.
The radiation oncology team can explain the expected benefits, treatment schedule and possible long-term effects.
4. Brachytherapy
Brachytherapy delivers radiation from a source placed inside or close to the prostate.
Depending on the technique, radioactive sources may be implanted temporarily or as permanent seeds. It may be appropriate for selected patients with localised prostate cancer.
Suitability depends on factors such as cancer risk, prostate size, urinary function and previous treatment.
Possible side effects include urinary irritation, difficulty urinating, bowel symptoms and changes in sexual function.
Brachytherapy is not suitable for every patient, and a specialist should explain whether it offers advantages over other treatment options.
5. Hormone Therapy for Prostate Cancer
Prostate cancer cells often depend on male hormones, particularly testosterone, to grow. Hormone therapy reduces the production or activity of these hormones.
It is also known as androgen deprivation therapy (ADT). It may be used for advanced disease or alongside radiation therapy for selected patients with higher-risk cancer.
Treatment may involve medicines that suppress hormone production, block androgen receptors or act through other hormonal pathways.
Gonadotropin-Releasing Hormone (GnRH) Medicines
GnRH agonists and antagonists reduce testosterone production through their effects on hormonal signalling.
These medicines may be given by injection or other prescribed formulations. The schedule depends on the medicine.
Hormone therapy may help control cancer growth, but it can cause side effects such as hot flashes, reduced libido, erectile dysfunction, fatigue, loss of muscle mass, increased body fat and reduced bone density.
Long-term treatment may also affect metabolic and cardiovascular health. Patients should discuss monitoring and preventive care with their medical team.
Hormone therapy does not suit every patient and may be combined with other medicines for advanced disease.
6. Chemotherapy for Prostate Cancer
Chemotherapy uses medicines to destroy cancer cells or slow their growth.
It may be recommended for selected patients with advanced or metastatic prostate cancer, particularly when the disease requires systemic treatment.
The choice and timing of chemotherapy depend on the cancer's characteristics, previous treatment, symptoms and overall health.
Possible side effects include fatigue, nausea, reduced blood cell counts, increased infection risk, hair loss with certain medicines and nerve symptoms.
The medical team will explain how treatment is administered, how often it is given and how side effects will be monitored.
7. Targeted Therapy and PSMA-Directed Treatment
Some prostate cancers have molecular changes that make them suitable for specific targeted medicines. For example, selected patients may benefit from treatments directed at particular DNA repair abnormalities.
Testing the tumour or inherited genetic factors may help determine whether these treatments are appropriate.
PSMA-directed treatment is another option for certain patients with advanced prostate cancer. PSMA is a protein commonly found at high levels on prostate cancer cells.
PSMA-targeted radioligand therapy uses a molecule that binds to PSMA and carries a radioactive substance to cancer cells. It may be suitable for selected patients with advanced disease after assessment of previous treatments and imaging results.
Possible side effects depend on the treatment and can include fatigue, blood cell changes, dry mouth with certain PSMA-targeted medicines and other organ-specific effects.
These treatments are not suitable for every patient and may only be available in certain clinical settings.
8. Minimally Invasive and Interventional Therapies
Some patients enquire about minimally invasive approaches for prostate cancer. These may include selected image-guided procedures, cryotherapy or other focal treatment techniques.
The term minimally invasive describes how a procedure is performed. It does not automatically mean that the treatment is safer, more effective or suitable for every cancer stage.
Interventional Therapy
Interventional procedures use imaging guidance to direct instruments, medicines or other treatments to a target area.
The exact technique, intended benefit and risks depend on the procedure. Patients should ask how the proposed intervention compares with established treatments for their particular cancer.
Cryotherapy
Cryotherapy uses extreme cold to destroy targeted tissue. It may be considered in selected clinical situations, including certain cases of recurrent prostate cancer after previous treatment.
Potential risks include urinary problems, erectile dysfunction, injury to nearby structures and other procedure-related complications.
Cryotherapy should not be presented as a universal replacement for surgery or radiation therapy. Its role depends on the patient's diagnosis and the available evidence.
Iodine-125 Seed Implantation
Iodine-125 seed implantation is a form of low-dose-rate brachytherapy in which small radioactive seeds are placed within the prostate to deliver radiation over time.
It may be suitable for selected patients with localised prostate cancer. The treatment requires careful planning and assessment of cancer risk and urinary function.
The expected benefits and possible complications should be discussed with a radiation oncology or urology specialist.
Nanoknife and Irreversible Electroporation
Irreversible electroporation, sometimes marketed as NanoKnife, uses electrical pulses to damage targeted cells.
Its role in prostate cancer is more limited than established standard treatments. It should not be described as a proven cure or as a method that reliably prevents recurrence.
Patients considering this procedure should ask about the strength of clinical evidence, the availability of long-term outcome data and whether treatment is offered within an appropriate clinical trial or registry.
9. Treatment for Metastatic Prostate Cancer
Metastatic prostate cancer has spread from the prostate to distant parts of the body, such as the bones or other organs.
Treatment usually involves medicines that act throughout the body. Depending on the circumstances, these may include hormone therapy, androgen receptor pathway inhibitors, chemotherapy, targeted medicines or PSMA-directed radioligand therapy.
Radiation therapy may help relieve pain from bone metastases or control selected areas of disease.
The treatment plan depends on whether the cancer remains sensitive to hormone suppression, the location and extent of spread, previous treatments and the patient's health.
Although metastatic prostate cancer is often not curable with current standard treatment, it can frequently be managed with a combination of therapies. Treatment goals and expected outcomes should be discussed with the specialist.
• Torturous Traditional Anticancer Technology
Operation: Big trauma and high risk; only suitable for early stage prostate cancer; cause serious damage to adjacent tissues and intestine, complications such as urinary incontinence, may even lead to infertility,
Radiotherapy and Chemotherapy: Unbearable toxic side effects, such as hair losing, vomiting and hypoimmunity etc. Chemoradiotherapy fails to achieve good efficacy for patient with advanced prostate cancer wit high chance of recurrence.
• Improve the Survival Rate of Prostate Cancer with New Technology
Minimally Invasive Therapy: 2-3mm incision, few side effects, little pain
Interventional Therapy: With 1-2 mm incision, local administration of drug, the drug concentration of interventional therapy is 2-8 times higher than that of systemic chemotherapy. It kills cancer cells more effectively with few toxic side effects.
Cryotherapy: Cryotherapy reduces the risks and complications from surgery. It also overcome the limitations of anesthesia and avoids the side effects of chemotherapy. Currently, this therapy has been successfully applied to numerous prostate cancer patients and able to obtain a great result.
Particle Implantation: These implanted 125I seeds will keep emitting y-ray within the tumor, targeting to the cancer cells accurately; the radiation of seeds to tumor lasts for 180 days, high accuracy, millimeter minimally invasive; few toxic side effects and complications.
Nanoknife: High voltage pulses released from electrode probes, resulting in multiple permanent nano-meters Irreversible Electroporation, breaking through cancer cells, accurately destroys cancer cells, protects blood vessels and nerves around the lesion, enhances the body's immune mechanism, rapidly metabolizes dead cancer cells and prevents recurrence.
Combination of Traditional Chinese Medicine & Western Medicine: Combining with advantages of traditional Chinese medicine and western medicine, tumor cells will be directly wiped out accurately and powerfully. also maximally reduces patient’s physical hurt due to treatment.
To know more about new technology for treating Prostate Cancer
What Are the Benefits and Risks of Prostate Cancer Treatment?
Every treatment involves potential benefits and risks. The right choice depends on the balance between cancer control, side effects and quality of life.
| Treatment | Potential benefit | Important considerations |
|---|---|---|
| Active surveillance | Avoids immediate treatment in suitable patients | Requires regular monitoring |
| Radical prostatectomy | Removes the prostate containing the tumour | Risks include urinary incontinence and erectile dysfunction |
| Radiation therapy | Treats cancer locally without removing the prostate | May cause urinary, bowel or sexual side effects |
| Hormone therapy | Helps control hormone-sensitive cancer | May affect sexual function, bones, muscles and metabolism |
| Chemotherapy | Treats cancer cells throughout the body | Can cause fatigue, low blood counts and other side effects |
| Targeted or PSMA-directed treatment | Provides a more specific approach for eligible patients | Requires suitable clinical or molecular findings and specialist assessment |
| Cryotherapy or other focal procedures | May target selected areas of cancer | Suitability and long-term outcomes vary |
This table is a general guide, not a ranking of treatment effectiveness.
Recovery and Follow-Up After Prostate Cancer Treatment
Recovery depends on the treatment received, the extent of the disease and the patient's overall health.
After radical prostatectomy, patients may need time to recover from surgery and may require support for urinary control and sexual function.
After radiation therapy, urinary or bowel symptoms may develop during treatment or later. Follow-up helps assess recovery and identify persistent side effects.
Hormone therapy requires monitoring for changes in bone health, metabolic health, energy levels and sexual function. Patients may benefit from appropriate exercise, nutrition and supportive care.
After treatment, doctors generally monitor PSA levels and assess symptoms. The frequency of follow-up depends on the treatment and the patient's risk of recurrence.
Patients should report new or worsening symptoms promptly, particularly difficulty passing urine, significant bleeding or persistent bone pain.
Frequently Asked Questions About Prostate Cancer Treatment
1. Can prostate cancer be treated successfully?
Yes. Many localised prostate cancers can be treated with the aim of curing the disease. Advanced prostate cancer can often be controlled with medicines and other treatments, although a cure is less likely when the cancer has spread to distant organs.
2. What is the best treatment for prostate cancer?
There is no single best treatment for every patient. Options include active surveillance, surgery, radiation therapy and systemic treatments. The most suitable approach depends on the cancer's stage, grade, PSA level, health status and the patient's preferences.
3. Can early-stage prostate cancer be treated without surgery?
Yes. Active surveillance may be suitable for selected patients with low-risk disease. Radiation therapy is another established option for patients who need treatment but do not undergo surgery.
4. What is the difference between active surveillance and watchful waiting?
Active surveillance involves regular tests to monitor the cancer, with the intention of offering treatment if it progresses. Watchful waiting generally focuses on managing symptoms if they develop and may be suitable for patients whose overall health or life expectancy makes curative treatment less beneficial.
5. Does hormone therapy cure prostate cancer?
Hormone therapy can control prostate cancer by reducing the effects of testosterone. It is commonly used for advanced disease and alongside radiation therapy in selected cases. It does not guarantee a cure, and the cancer may eventually become resistant to hormone suppression.
6. What are the side effects of prostate cancer surgery?
Possible side effects include urinary incontinence, erectile dysfunction, bleeding, infection and other surgical complications. The likelihood and severity depend on the procedure, the cancer's extent and individual factors
.
7. Is radiation therapy better than surgery?
Neither treatment is universally better. Both can be appropriate for selected patients with localised prostate cancer. Doctors compare expected cancer control, side effects, existing health conditions and personal preferences when recommending treatment.
8. Can metastatic prostate cancer be treated?
Yes. Treatment may include hormone therapy, additional hormone-blocking medicines, chemotherapy, targeted therapy and selected radiopharmaceutical treatments. The aim is usually to control the disease, relieve symptoms and maintain quality of life.
9. What is PSMA PET/CT, and why might it be recommended?
PSMA PET/CT is an imaging test that can help identify prostate cancer in the prostate region or other parts of the body. It may be recommended for selected patients during staging or when recurrence is suspected. It is not required for every patient.
10. Can minimally invasive treatments replace standard prostate cancer treatment?
Not in every case. Some minimally invasive procedures are suitable for specific patients, but their effectiveness and risks vary. Patients should ask a specialist whether the procedure is supported by clinical evidence for their particular diagnosis and how it compares with standard treatment.
Explore Your Prostate Cancer Treatment Options
Choosing a prostate cancer treatment plan requires an understanding of the diagnosis, the likely benefits of treatment and the potential risks.
Modern Cancer Hospital Guangzhou Malaysia welcomes enquiries from patients who wish to learn more about available cancer care approaches.
Contact our team to enquire about prostate cancer treatment options and arrange a consultation.
Every patient requires an individual medical assessment. No treatment can guarantee a cure or a specific outcome.
